Afuco™ Anti-Human CLEC2D ADCC Theraputic Antibody, ADCC Enhanced
Product Quick Detail
- Minimum Order
- 1
- Place Of Origin
- USA
- Packaging
- N/A
- Delivery
- 15 Days
Specifications
Anti-CLEC2D ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody that is capable of specifically binding to lectin-like transcript
1 (LLT1), to polynucleotides encoding such antibodies and to cells that express such antibodies. Antibodies have utility in the treatment of autoimmune diseases and cancer, in which LLT1- and
CD161-expressing cells play a role in disease pathogenesis.
https://www.creativebiolabs.net/Anti-CLEC2D-ADCC-Enhanced-Antibody-20469.htm
- Country: United States
- Business Type:
- Market:
- Founded Year:2005
- Address:
- Contact:Jerry Carter
